Categories AlphaGraphs, Earnings, LATEST
Ford Motor (F) Q3 earnings beat; stock falls on weak guidance
Ford Motor Company (NYSE: F) reported an increase in third-quarter earnings, despite a decline in revenues. Earnings came in above Wall Street’s prediction. The stock slipped during Wednesday’s after-hours session as the company trimmed its full-year guidance.
Earnings Beat
Third-quarter profit, on an adjusted basis, rose to $0.34 per share from $0.29 per share last year and topped the Street view. Unadjusted net income was $425 million or $0.11 per share, down from last year’s profit of $991 million or $0.25 per share.
“Our Global Redesign is about making choices to transform our organization, to become the world’s most trusted company and a clear leader in an era of rapid change. We are getting stronger today and we have more work to do,” said CEO Jim Hackett.
Revenue declined by 2% year-over-year to $37 billion, reflecting the faltering demand and unfavorable exchange rates. The top-line, meanwhile, exceeded expectations.
Outlook
The company said it continues to expect lower full-year structural costs in the Automotive business and anticipates full-year growth in adjusted free cash flow. Meanwhile, it lowered the full-year adjusted EBIT guidance to between $6.5 billion and $7.0 billion, to reflect the increase in warranty costs, higher than planned incentives in North America, and lower volumes in China.
Related: Ford Motor Q2 2019 Earnings Call Transcript
Full-year adjusted earnings are currently expected to be between $1.20 per share to $1.32 per share, down from the last year’s levels. The estimated adjusted effective tax rate is 12-13%.
Ford’s stock closed Wednesday’s session near the levels seen a year earlier. It is yet to recover from the losses that followed the dismal second-quarter performance. The stock dropped sharply Wednesday evening following the earnings report.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on